NeuroVoices: Rebecca M. Edelmayer, PhD, on Advancing Blood Biomarkers in Alzheimer Disease for Earlier Diagnosis and Treatment Intervention

NewsEducation
Written By Emily Scholler
Emily Scholler
Previous

Clinical use of biomarkers in the era of Alzheimer's disease treatments
Next

VJNeurology Webinar: Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases.